EMERGING OPTIONS IN DEVELOPMENT FOR TREATMENT OF FILOVIRUS INFECTIONS

被引：1
|
作者：
Cardile, A. P. [1 ]
Mayers, D. L. [2 ]
Bavari, S. [3 ]
机构：
[1] US Army Med Res, Inst Infect Dis, Div Med, Frederick, MD 21702 USA
[2] US Army Med Res, Inst Infect Dis, Therapeut Dev Ctr, Frederick, MD 21702 USA
[3] US Army Med Res, Inst Infect Dis, Frederick, MD 21702 USA
来源：
DRUGS OF THE FUTURE | 2015年 / 40卷 / 11期
关键词：
Ebola; Marburg; BCX-4433; Brincidofovir; Favipiravir; Small-interfering RNAs; Antisense phosphorodiamidate; Morpholino oligomers; Interferon; FX-06; zMapp; Recombinant nematode anticoagulant protein c2; Convalescent plasma; Amodiaquine; EBOLA-VIRUS DISEASE; MARBURG VIRUS; NONHUMAN-PRIMATES; RNA INTERFERENCE; CONVALESCENT PLASMA; HEMORRHAGIC-FEVER; FAVIPIRAVIR T-705; POSTEXPOSURE PROTECTION; NUCLEOSIDE ANALOG; YELLOW-FEVER;
D O I：
10.1358/dof.2015.040.11.2387219
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
As a result of the ongoing Ebola outbreak in West Africa, there have been significant developments in therapeutics against Filovirus over the past year. Not only have novel therapeutics been advanced, but a number of already-approved drugs have demonstrated activity against Ebola virus. This review article summarizes the most important therapeutic agents for both Ebola and Marburg virus. Among the therapeutics discussed, small-molecule inhibitors, nucleic acid-based therapeutics, immune-therapeutics (zMapp, convalescent plasma) and repurposed drugs are all included.
引用
收藏
页码：727 / 738
页数：12
相关论文
共 50 条
  • [1] Mouse Models for Filovirus Infections
    Bradfute, Steven B.
    Warfield, Kelly L.
    Bray, Mike
    VIRUSES-BASEL, 2012, 4 (09): : 1477 - 1508
  • [2] Pre-symptomatic diagnosis and treatment of filovirus diseases
    Shurtleff, Amy C.
    Whitehouse, Chris A.
    Ward, Michael D.
    Cazares, Lisa H.
    Bavari, Sina
    FRONTIERS IN MICROBIOLOGY, 2015, 6
  • [3] Toward RNA Interference-Based Therapy for Filovirus Infections
    Spurgers, Kevin B.
    Silvestri, Lynn S.
    Warfield, Kelly L.
    Bavari, Sina
    DRUG DEVELOPMENT RESEARCH, 2009, 70 (04) : 246 - 254
  • [4] Development of experimental and early investigational drugs for the treatment of Ebola virus infections
    Wong, Gary
    Qiu, Xiangguo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (08) : 999 - 1011
  • [5] Potential and Emerging Treatment Options for Ebola Virus Disease
    Bishop, Bryan M.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (02) : 196 - 206
  • [6] Filovirus Hemorrhagic Fever Outbreak Case Management: A Review of Current and Future Treatment Options
    Roddy, Paul
    Colebunders, Robert
    Jeffs, Benjamin
    Palma, Pedro Pablo
    Van Herp, Michel
    Borchert, Matthias
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 : S791 - S795
  • [7] Selection of Filovirus Isolates for Vaccine Development Programs
    Wolfe, Daniel N.
    Sabourin, Carol L.
    Merchlinsky, Michael J.
    Florence, William C.
    Wolfraim, Larry A.
    Taylor, Kimberly L.
    Ward, Lucy A.
    VACCINES, 2021, 9 (09)
  • [8] Post-exposure therapy of filovirus infections
    Wong, Gary
    Qiu, Xiangguo
    Olinger, Gene G.
    Kobinger, Gary P.
    TRENDS IN MICROBIOLOGY, 2014, 22 (08) : 456 - 463
  • [9] Treatment-focused Ebola trials, supportive care and future of filovirus care
    Keshtkar-Jahromi, Maryam
    Martins, Karen A. O.
    Cardile, Anthony P.
    Reisler, Ronald B.
    Christopher, George W.
    Bavari, Sina
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (01) : 67 - 76
  • [10] Animal models for filovirus infections
    Siragam, Vinayakumar
    Wong, Gary
    Qiu, Xiang-Guo
    ZOOLOGICAL RESEARCH, 2018, 39 (01) : 15 - 24
12345